loading
home
Introduction
the Research Program PRETORIAN

Τhe PRETORIAN project is dedicated to harnessing experimental discoveries concerning two novel chemical structures displaying remarkable anti-cancer properties. These discoveries are being advanced as pioneering therapeutic agents for cancer treatment.

The selection of the PRETORIAN compounds followed a rigorous evaluation process, involving the assessment of the biological activities of hundreds chemical compounds by the research teams led by Professors Aristides Eliopoulos (School of Medicine, National and Kapodistrian University of Athens) and George Vasilikogiannakis (Department of Chemistry, University of Crete). he most potent compound served as blueprint for the synthesis of derivatives, with the goal of amplifying their biological efficacy. This resulted in the development of two distinct chemical structures derived from the original compound.

The PRETORIAN project is funded by the General Secretariat for Research and Technology of Greece for the preclinical evaluation of these innovative compounds, with the following specific objectives:

The Mission
specific objectives
Images
Anticancer activity in cancer cell lines

Comprehensive in vitro and in vivo evaluation as monotherapies or in combination with other chemotherapeutic or biological agents.

Images
Mechanistic studies

Determining the impact of the compounds on biological networks.

Images
Molecular targets

Assessing the conversion of pro-drug molecules into active final compounds.

Images
In vivo preclinical models

Conducting toxicological analyses in experimental animals (mice).

Images
Toxicity studies

Securing intellectual property rights (patents) and developing commercialization strategies for the results.

news
News and Latest Research Findings
To Top
en_US
Skip to content